Psychedelic trials recruiting in Europe (2026): psilocybin, MDMA, LSD and ketamine studies by country
The short answer. As of 19 November 2026, we list 27 psychedelic and ketamine-assisted therapy trials that public registries show as recruiting with at least one site in the UK or Europe. 16 of them test psilocybin or psilocin. The records come from ClinicalTrials.gov, the EU's CTIS register and ISRCTN (14 from ClinicalTrials.gov, 9 from EU CTIS, 4 from ISRCTN), and each links to its registry entry.
In the UK and most of Europe, a clinical trial is the main lawful way to receive these substances. Filter by country or substance below. The full data is in our directory.
Recruiting trials
Showing all 27 trials.
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
- Substance
- Psilocybin
- Condition
- Major Depressive Disorder (MDD), Depression in Adults, Depression - Major Depressive Disorder
- Sponsor
- Cybin IRL Limited
- Phase
- Phase 3
- European sites
- Czechia, Germany, Greece, Ireland, Poland, United Kingdom (also: Australia, United States)
- Status
- Recruiting (ClinicalTrials.gov)
- Registry record
- ClinicalTrials.gov NCT06793397
- Last checked
- 19 November 2026
PsiloIMAGINE: A Psychedelic-augmented Mental Imagery-based Intervention for Young People With Self-harm
- Substance
- Psilocybin
- Condition
- Self Harm
- Sponsor
- Imperial College London
- Phase
- Early phase 1
- European sites
- United Kingdom
- Status
- Recruiting (ClinicalTrials.gov)
- Registry record
- ClinicalTrials.gov NCT06798636
- Last checked
- 19 November 2026
PsilOpioid: psilocybin therapy in opioid use disorder
- Substance
- Psilocybin
- Condition
- Opioid use disorder
- Sponsor
- Imperial College London (NIHR Imperial Clinical Research Facility)
- European sites
- United Kingdom
- Status
- Recruitment window open (ISRCTN)
- Registry record
- ISRCTN10232579
- Last checked
- 19 November 2026
Sleep Blinding Psilocybin: feasibility study
- Substance
- Psilocybin
- Condition
- Depression
- Sponsor
- South London and Maudsley NHS Foundation Trust
- European sites
- United Kingdom
- Status
- Recruitment window open (ISRCTN)
- Registry record
- ISRCTN10648713
- Last checked
- 19 November 2026
Ketamine for depression with anorexia nervosa (feasibility RCT)
- Substance
- Ketamine
- Condition
- Depression with anorexia nervosa
- Sponsor
- King's College London
- European sites
- United Kingdom
- Status
- Recruitment window open (ISRCTN)
- Registry record
- ISRCTN26462355
- Last checked
- 19 November 2026
MORE-KARE: ketamine-assisted psychological therapy to reduce alcohol relapse
- Substance
- Ketamine
- Condition
- Severe alcohol use disorder
- Sponsor
- University of Exeter (multi-centre NHS sites)
- European sites
- United Kingdom
- Status
- Recruitment window open (ISRCTN)
- Registry record
- ISRCTN85955128
- Last checked
- 19 November 2026
Elucidating the Relevance of the Psychedelic Experience to Psilocybin's Anti-Anhedonic Effects
- Substance
- Psilocybin
- Condition
- Depression - Major Depressive Disorder, Anhedonia
- Sponsor
- Medical University of Vienna
- Phase
- Phase 1
- European sites
- Austria
- Status
- Recruiting (ClinicalTrials.gov)
- Registry record
- ClinicalTrials.gov NCT07490353
- Last checked
- 19 November 2026
Psilocybin Therapy for Psychological Distress in Palliative Patients
- Substance
- Psilocybin
- Condition
- COPD (Chronic Obstructive Pulmonary Disease), ALS (Amyotrophic Lateral Sclerosis), MS (Multiple Sclerosis)
- Sponsor
- University Medical Center Groningen
- Phase
- Phase 2
- European sites
- Czechia, Denmark, Netherlands, Portugal
- Status
- Recruiting (ClinicalTrials.gov)
- Registry record
- ClinicalTrials.gov NCT06782724
- Last checked
- 19 November 2026
Efficacy of psilocybin and trazodone combination in treatment-resistant depression: a randomized controlled proof-of-concept study (PSILOTRAZ)
- Substance
- Psilocybin
- Condition
- Treatment-resistant depression
- Sponsor
- Groupe Hospitalier Universitaire Paris Psychiatrie & Neuroscience
- European sites
- France
- Status
- Ongoing, recruiting (EU CTIS)
- Registry record
- EU CTIS 2024-512911-34-00
- Last checked
- 19 November 2026
ERPPAD - Efficacy in Relapse Prevention: Psilocybin in Alcohol use disorder with Depressive symptoms
- Substance
- Psilocybin
- Condition
- Alcohol use disorder, depressive symptoms
- Sponsor
- Centre Hospitalier Universitaire De Nimes
- European sites
- France
- Status
- Ongoing, recruiting (EU CTIS)
- Registry record
- EU CTIS 2025-525069-65-00
- Last checked
- 19 November 2026
Psilocybin AsSisted pSychotherapy for the treatmENt of Gambling disordER : a pilot study
- Substance
- Psilocybin
- Condition
- Gambling disorder
- Sponsor
- Centre Hospitalier Universitaire De Nantes
- European sites
- France
- Status
- Ongoing, recruiting (EU CTIS)
- Registry record
- EU CTIS 2025-522743-18-00
- Last checked
- 19 November 2026
POSITRON - PsilOcybin with pSychologIcal supporT foR cOcaiNe: a randomised controlled pilot feasibility trial of psilocybin with psychological support for cocaine use disorder
- Substance
- Psilocybin
- Condition
- Cocaine addiction
- Sponsor
- Trinity College Dublin
- European sites
- Ireland
- Status
- Ongoing, recruiting (EU CTIS)
- Registry record
- EU CTIS 2024-515147-32-02
- Last checked
- 19 November 2026
Psilocybin versus Personalized Neuromodulation for Resistant Depression (PSILO-MODULATION)
- Substance
- Psilocybin
- Condition
- Treatment Resistant Depression (TRD)
- Sponsor
- Universita' Degli Studi G. D'Annunzio Di Chieti
- European sites
- Italy
- Status
- Ongoing, recruiting (EU CTIS)
- Registry record
- EU CTIS 2024-519844-34-03
- Last checked
- 19 November 2026
Trazodone’s Effects on Moderation of Psilocybin Outcomes (TEMPO)
- Substance
- Psilocybin
- Condition
- Treatment-Resistant Depression
- Sponsor
- Universita' Degli Studi G. D'Annunzio Di Chieti
- European sites
- Italy
- Status
- Ongoing, recruiting (EU CTIS)
- Registry record
- EU CTIS 2025-523346-27-00
- Last checked
- 19 November 2026
A double-blind, randomized, controlled trial on the effect of PEX010 for prolonged grief disorder
- Substance
- Psilocybin
- Condition
- Prolonged grief disorder
- Sponsor
- Linkopings Universitet
- European sites
- Sweden
- Status
- Ongoing, recruiting (EU CTIS)
- Registry record
- EU CTIS 2024-518218-24-00
- Last checked
- 19 November 2026
CAPSI - Cancer related major depression treated with a single dose of psilocybin - a multicenter randomized placebo controlled double blind clinical trial
- Substance
- Psilocybin
- Condition
- Major Depressive Disorder, Malignant tumours ICD 10 C00 to C97
- Sponsor
- Region Stockholm – SLSO
- European sites
- Sweden
- Status
- Ongoing, recruiting (EU CTIS)
- Registry record
- EU CTIS 2023-505532-35-00
- Last checked
- 19 November 2026
Safety, Therapeutic Potential, and Mechanisms of Two Psilocybin Doses, Administered With Psychological Support in Young Adults With Anorexia Nervosa
- Substance
- Psilocybin
- Condition
- Anorexia Nervosa
- Sponsor
- Region Skane
- Phase
- Phase 2
- European sites
- Sweden
- Status
- Recruiting (ClinicalTrials.gov)
- Registry record
- ClinicalTrials.gov NCT07169747
- Last checked
- 19 November 2026
The therapeutic potential of psilocybin in anorexia nervosa in young adults
- Substance
- Psilocybin
- Condition
- Anorexia Nervosa
- Sponsor
- Region Skane
- European sites
- Sweden
- Status
- Ongoing, recruiting (EU CTIS)
- Registry record
- EU CTIS 2024-515163-63-00
- Last checked
- 19 November 2026
LSD to Improve Cluster Headache Impact Trial
- Substance
- LSD
- Condition
- Chronic Cluster Headache
- Sponsor
- Radboud University Medical Center
- Phase
- Phase 2
- European sites
- Netherlands
- Status
- Recruiting (ClinicalTrials.gov)
- Registry record
- ClinicalTrials.gov NCT05477459
- Last checked
- 19 November 2026
LSD Treatment for Persons With Alcohol Use Disorder
- Substance
- LSD
- Condition
- Alcohol Use Disorder (AUD)
- Sponsor
- Felix Mueller
- Phase
- Phase 2
- European sites
- Switzerland
- Status
- Recruiting (ClinicalTrials.gov)
- Registry record
- ClinicalTrials.gov NCT05474989
- Last checked
- 19 November 2026
Lysergic Acid Diethylamide (LSD) in Palliative Care
- Substance
- LSD
- Condition
- Palliative Care, Pain, Anxiety
- Sponsor
- University Hospital, Basel, Switzerland
- Phase
- Phase 2
- European sites
- Switzerland
- Status
- Recruiting (ClinicalTrials.gov)
- Registry record
- ClinicalTrials.gov NCT05883540
- Last checked
- 19 November 2026
Antidepressant Response of DMT Masked With Propofol
- Substance
- DMT
- Condition
- Major Depressive Disorder, Psychedelic Experiences
- Sponsor
- University Hospital, Basel, Switzerland
- European sites
- Switzerland
- Status
- Recruiting (ClinicalTrials.gov)
- Registry record
- ClinicalTrials.gov NCT06927076
- Last checked
- 19 November 2026
Ketamine in OCD: Efficacy and Effects on Stress and Cognition
- Substance
- Ketamine
- Condition
- Obsessive-Compulsive Disorder, Psychiatric Disorder
- Sponsor
- Medical University of Vienna
- European sites
- Austria
- Status
- Recruiting (ClinicalTrials.gov)
- Registry record
- ClinicalTrials.gov NCT05577585
- Last checked
- 19 November 2026
Pharmacologic Treatment Augmentation in Chronic Depression
- Substance
- Ketamine
- Condition
- Major Depressive Disorder
- Sponsor
- University Hospital Tuebingen
- Phase
- Phase 2
- European sites
- Germany
- Status
- Recruiting (ClinicalTrials.gov)
- Registry record
- ClinicalTrials.gov NCT06410599
- Last checked
- 19 November 2026
Ketamine Augmentation of ECT in Treatment-Resistant Depression
- Substance
- Ketamine
- Condition
- Major Depressive Disorder, Treatment Resistant Depression
- Sponsor
- Università Vita-Salute San Raffaele
- Phase
- Phase 3
- European sites
- Italy
- Status
- Recruiting (ClinicalTrials.gov)
- Registry record
- ClinicalTrials.gov NCT07088380
- Last checked
- 19 November 2026
Working Mechanisms and Effectiveness of IV Ketamine-assisted Psychotherapy on Depression in TRD Clients
- Substance
- Ketamine
- Condition
- Treatment Resistant Depression
- Sponsor
- Senz
- European sites
- Netherlands
- Status
- Recruiting (ClinicalTrials.gov)
- Registry record
- ClinicalTrials.gov NCT07706478
- Last checked
- 19 November 2026
Ketamine for Combined Depression and Alcohol Use Disorder
- Substance
- Ketamine
- Condition
- Depression, Alcohol Use Disorder
- Sponsor
- University Hospital of North Norway
- Phase
- Phase 1, Phase 2
- European sites
- Norway
- Status
- Recruiting (ClinicalTrials.gov)
- Registry record
- ClinicalTrials.gov NCT06090422
- Last checked
- 19 November 2026
Trials by country
A trial with sites in several countries is counted once for each.
| Country | Recruiting trials in our list |
|---|---|
| United Kingdom | 6 |
| Austria | 2 |
| Czechia | 2 |
| Denmark | 1 |
| France | 3 |
| Germany | 2 |
| Greece | 1 |
| Ireland | 2 |
| Italy | 3 |
| Netherlands | 3 |
| Norway | 1 |
| Poland | 1 |
| Portugal | 1 |
| Sweden | 4 |
| Switzerland | 3 |
How this list is made
- Sources. Each week we re-check every trial in our directory against its registry: ClinicalTrials.gov, the EU Clinical Trials Information System and the UK-based ISRCTN registry. Trials no longer shown as recruiting are removed.
- What we include. Trials of psychedelic-assisted or ketamine-assisted treatment in patients with at least one site in the UK or Europe. Ketamine and esketamine trials are labelled separately because they are licensed medicines being tested in new ways.
- What we leave out. Pharmacology studies in healthy volunteers, studies where the psychedelic is not the treatment being tested, and records that look stale, for example where the registered end date has passed with no sign of recent activity. Some method studies, such as the UK SLEEPY study, recruit healthy volunteers and are marked as such in their record.
- Status means the registry's status. "Recruiting" is what the registry said on the date shown. Individual sites may be closed or not yet open.
Country guides: UK psilocybin trials · Germany · Czechia · Switzerland. Licensing status for each medicine is on the approval tracker.
Questions and answers
Are psilocybin trials recruiting in Europe?
Yes. As of 19 November 2026, our list has 16 psilocybin or psilocin trials that the registries show as recruiting with at least one site in the UK or Europe, out of 27 psychedelic and ketamine-assisted therapy trials in total.
Which European countries have psychedelic trials recruiting?
In our list as of 19 November 2026, the countries with the most recruiting trials are United Kingdom (6), Sweden (4), Netherlands (3), France (3), Italy (3). A multi-country trial counts once for each country with a listed site.
How do I take part in a psychedelic trial?
Open the registry record, check who can take part, and contact the study team listed there. Trials have strict eligibility rules and screening. Talk to your own doctor first, and do not stop any medication on your own.
Can I join a trial in another country?
Sometimes, but many trials only recruit people who live near a site and can attend every visit, and some only recruit through local health services. The registry record and the study team can tell you.
Why is a trial I know about missing?
We list only trials that a public registry shows as recruiting, with a site in the UK or Europe, and that test psychedelic-assisted or ketamine-assisted treatment in patients. We leave out pharmacology studies in healthy volunteers and records that look stale, for example where the registered end date has passed with no sign of recent activity. Email us if we have missed one.
Is this list complete?
No. It is a curated list that we check each week against ClinicalTrials.gov, the EU's CTIS register and ISRCTN. Use it as a starting point and check the registries directly.
Get UK and Europe access news each week
New trials, regulator decisions and law changes, with every claim linked to its source. Free, one email a week.
Subscribe free →Sources
Each trial links to its own registry record, checked on the date shown on its card.
- ClinicalTrials.gov (US National Library of Medicine). https://clinicaltrials.gov/
- EU Clinical Trials Information System (CTIS): search for clinical trials. https://euclinicaltrials.eu/search-for-clinical-trials/?lang=en
- ISRCTN registry. https://www.isrctn.com/